DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...
Everyday Health on MSN
How to manage 6 common challenges of living with thyroid eye disease
What to know about medical treatments, lifestyle adjustments, and more to navigate life with TED.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results